PHARMIDEX PHARMACEUTICAL SERVICES LIMITED
ActiveCompany number 04441512
London, United Kingdom · Incorporated 17 May 2002
167-169 Great Portland Street, Fifth Floor, London, W1W 5PF, United Kingdom
Last updated on 18 September 2026
Research and experimental development on biotechnology · SIC 72110
Company overview
PHARMIDEX PHARMACEUTICAL SERVICES LIMITED is a private limited company registered in England and Wales since its incorporation on 17 May 2002 and remains active on the register. Its registered office is at 167-169 Great Portland Street, Fifth Floor, London, W1W 5PF, United Kingdom. Its principal activity is research and experimental development on biotechnology (SIC 72110).
It is controlled by Pharmidex Holdings Ltd, which holds 75-100% of the shares. The board consists of two British directors: SADEGHI-ALAVIJEH, Mohammad, Professor (appointed 17 May 2002) and A2E CAPITAL PARTNERS LIMITED (appointed 11 March 2011). SADEGHI-ALAVIJEH, Mohammad, Professor serves as company secretary (appointed 17 May 2002). Five former officers have previously served the company.
No charges are registered against the company, and it has neither an insolvency history nor a past liquidation. Its most recent total-exemption-full accounts, made up to 30 June 2025, were filed on 29 April 2026. The next accounts are due by 3 November 2026. The latest confirmation statement was made up to 17 May 2026. The next is due by 31 May 2027. Companies House holds 146 filings for this company, most recently an accounts filing on 3 August 2026.
Compliance
Financial snapshot
| Year ended | Fixed assets | Current assets | Net assets/liabilities | Change |
|---|---|---|---|---|
| — | — | — | — | — |
| — | — | — | — | — |
| — | — | — | — | — |
| — | — | — | — | — |
| — | — | — | — | — |
| — | — | — | — | — |
| — | — | — | — | — |
| — | — | — | — | — |
| — | — | — | — | — |
| — | — | — | — | — |
| — | — | — | — | — |
| — | — | — | — | — |
| — | — | — | — | — |
| — | — | — | — | — |
| — | — | — | — | — |
| — | — | — | — | — |
| — | — | — | — | — |
| — | — | — | — | — |
| — | — | — | — | — |
| — | — | — | — | — |
| — | — | — | — | — |
| — | — | — | — | — |
Capital table
Updated on 18 September 2026Share classes
| Class | Allocated shares | Currency | Nominal value | Voting | Dividend | Transfer | Anti-dilution |
|---|---|---|---|---|---|---|---|
| ORDINARY | 19,611 | GBP | £19,611.000 | ||||
| REDEEMABLE | 116,688 | GBP | £116,688.000 | ||||
| Total | 0 | ||||||
Officers
Persons with significant control
Funding
1 funding roundFiling history
No filings match this type.
Risk at a glance
- Company active
- Accounts up to date
- Confirmation statement up to date
- No insolvency history
- No registered charges
- Credit score
- Recommended limit
- Payment risk
Get the complete credit report
- Detailed financial statements
- Credit score & payment risk
- CCJs, charges & insolvency checks
- Recommended credit limit
Secure checkout · Report delivered instantly
Related companies
Sharing officers with this company